Alteration of inflammatory mediators in patients with obstructive sleep apnea Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Serum midkine levels in patients with obstructive sleep apnea Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Subclinical atherosclerosis in obstructive sleep apnea (OSA): The EPIOSA study Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine Year: 2015
Serum levels of adipokines in obstructive sleep apnea Source: International Congress 2015 – Monitoring sleep-disordered breathing in children and adults Year: 2015
Serum omentin levels in patients with obstructive sleep apnea syndrome Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Relationship between obstructive sleep apnea syndrome, plasma homocysteine levels and cardiovascular risk Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Markers of liver dysfunction in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011
Renin and aldosterone levels in obstructive sleep apnea syndrome patients Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
The association between hypertension and neutrophil to lymphocyte ratio in patients with obstructive sleep apnea syndrome Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Serum YKL-40 level is associated with apnea hypopnea index in patients with obstructive sleep apnea syndrome Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014
Evaluation of lipid profile in patients with obstructive sleep apnea syndrome Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II Year: 2015
Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA) Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing Year: 2015
Relationship between echocardiographic assessment and plasma endothelin-1 levels in obese patients with or without obstructive sleep apnea Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015
Is snoring the cause of oxidative stress in airways in obstructive sleep apnea patients? Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Association between lipid peroxidation and inflammation in obstructive sleep apnoea Source: Eur Respir J 2006; 28: 378-385 Year: 2006
Obstructive sleep apnoea and increased inflammatory activity in non-obese patients with coronary artery disease in the RICCADSA trial Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013
Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea Source: International Congress 2019 – State of the art session: Sleep and breathing disorders Year: 2019